Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer
Crossref DOI link: https://doi.org/10.1186/s13014-016-0587-9
Published Online: 2016-01-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamashita, Hideomi
Haga, Akihiro
Takenaka, Ryousuke
Kiritoshi, Tomoki
Okuma, Kae
Ohtomo, Kuni
Nakagawa, Keiichi